1.
DEPO MEDROKSI PROGESTERON ASETAT (DMPA) INCREASES BODY MASS INDEX OF ACCEPTORS BUT DECREASES THEIR LIBIDO. Proceedings of the ICASH. 2017;(2):81-85. Accessed November 7, 2024. https://publications.inschool.id/index.php/icash/article/view/880